Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles

Biomaterials

Volumn 34, Issue 21, 2013, Pages 5369-5380

  Almalik, Abdulaziz ^a   Karimi, Shima ^a,b   Ouasti, Sihem ^a,d   Donno, Roberto ^a   Wandrey, Christine ^b   Day, Philip J ^c   Tirelli, Nicola ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b EPFL   (Switzerland)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Alginate; CD44; Endocytosis; Hyaluronic acid; Nanoparticles

Indexed keywords

CD44; COATING AGENTS; DEGREE OF CLUSTERING; ENDOCYTOSIS; INDIVIDUAL NANOPARTICLES; MURINE MACROPHAGES; NANOPARTICLE STRUCTURES; PHAGOCYTIC CELLS;

ALGINATE; MOLECULAR BIOLOGY; NANOPARTICLES; ORGANIC ACIDS;

HYALURONIC ACID;

ALGINIC ACID; CHITOSAN; HERMES ANTIGEN; HYALURONIC ACID; NANOPARTICLE; PHOSPHATE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL INTERACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOFLUOROMETRY; DISPERSION; ENDOCYTOSIS; INTERNALIZATION; LEUKOCYTE; MACROPHAGE; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATIC ELECTRICITY;

ALGINATES; ANIMALS; ANTIGENS, CD44; CELL LINE; CELL SURVIVAL; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; CULTURE MEDIA; ENDOCYTOSIS; GLUCURONIC ACID; HEXURONIC ACIDS; HYALURONIC ACID; INTRACELLULAR SPACE; KINETICS; MACROPHAGES; MICE; MOLECULAR WEIGHT; NANOPARTICLES; PARTICLE SIZE; POLYPHOSPHATES;

MURINAE;

EID: 84877022519     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.03.065     Document Type: Article

References (45)

1. Ghosh S.C., Alpay S.N., Klostergaard J. Cd44: a validated target for improved delivery of cancer therapeutics. Expert Opin Ther Targets 2012, 16:635-650.
2. Negi L.M., Talegaonkar S., Jaggi M., Ahmad F.J., Iqbal Z., Khar R.K. Role of cd44 intumour progression and strategies for targeting. JDrug Target 2012, 20:561-573.
3. Coradini D., Pellizzaro C., Miglierini G., Daidone M.G., Perbellini A. Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line. Int J Cancer 1999, 81:411-416.
4. Auzenne E., Ghosh S.C., Khodadadian M., Rivera B., Farquhar D., Price R.E., et al. Hyaluronic acid-paclitaxel: antitumor efficacy against cd44(+) human ovarian carcinoma xenografts. Neoplasia 2007, 9:479-486.
5. Choi K.Y., Chung H., Min K.H., Yoon H.Y., Kim K., Park J.H., et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 2010, 31:106-114.
6. Lee H., Ahn C.-H., Park T.G. Poly lactic-co-(glycolic acid) -grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin. Macromol Biosci 2009, 9:336-342.
7. Lee H., Mok H., Lee S., Oh Y.-K., Park T.G. Target-specific intracellular delivery of sirna using degradable hyaluronic acid nanogels. JControl Release 2007, 119:245-252.
8. Choi K.Y., Min K.H., Yoon H.Y., Kim K., Park J.H., Kwon I.C., et al. Pegylation of hyaluronic acid nanoparticles improves tumor targetability invivo. Biomaterials 2011, 32:1880-1889.
9. Choi K.Y., Saravanakumar G., Park J.H., Park K. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf B Biointerfaces 2012, 99:82-94.
10. Ossipov D.A. Nanostructured hyaluronic acid-based materials for active delivery to cancer. Expert Opin Drug Deliv 2010, 7:681-703.
11. Hyung W., Ko H., Park J., Lim E., Park S.B., Park Y.-J., et al. Novel hyaluronic acid (ha) coated drug carriers (hcdcs) for human breast cancer treatment. Biotechnol Bioeng 2008, 99:442-454.
12. Coradini D., Zorzet S., Rossin R., Scarlata I., Pellizzaro C., Turrin C., et al. Inhibition of hepatocellular carcinomas invitro and hepatic metastases invivo in mice by the histone deacetylase inhibitor ha-but. Clin Cancer Res 2004, 10:4822-4830.
13. Ouasti S., Kingham P.J., Terenghi G., Tirelli N. The cd44/integrins interplay and the significance of receptor binding and re-presentation in the uptake of rgd-functionalized hyaluronic acid. Biomaterials 2012, 33:1120-1134.
14. Pure E., Cuff C.A. Acrucial role for cd44 in inflammation. Trends Mol Med 2001, 7:213-221.
15. Teder P., Vandivier R.W., Jiang D.H., Liang J.R., Cohn L., Pure E., et al. Resolution of lung inflammation by cd44. Science 2002, 296:155-158.
16. Wolny P.M., Banerji S., Gounou C., Brisson A.R., Day A.J., Jackson D.G., et al. Analysis of cd44-hyaluronan interactions in an artificial membrane system insights into the distinct binding properties of high and low molecular weight hyaluronan. JBiol Chem 2010, 285:30170-30180.
17. de la Motte C.A., Hascall V.C., Drazba J., Bandyopadhyay S.K., Strong S.A. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid - inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 2003, 163:121-133.
18. Jokela T.A., Lindgren A., Rilla K., Maytin E., Hascall V.C., Tammi R.H., et al. Induction of hyaluronan cables and monocyte adherence in epidermal keratinocytes. Connect Tissue Res 2008, 49:115-119.
19. Lesley J., Gal I., Mahoney D.J., Cordell M.R., Rugg M.S., Hyman R., et al. Tsg-6 modulates the interaction between hyaluronan and cell surface cd44. JBiol Chem 2004, 279:25745-25754.
20. Ding H.M., Ma Y.Q. Role of physicochemical properties of coating ligands inreceptor-mediated endocytosis of nanoparticles. Biomaterials 2012, 33:5798-5802.
21. Laroui H., Grossin L., Leonard M., Stoltz J.F., Gillet P., Netter P., et al. Hyaluronate-covered nanoparticles for the therapeutic targeting of cartilage. Biomacromolecules 2007, 8:3879-3885.
22. Zaki N.M., Nasti A., Tirelli N. Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model. Macromol Biosci 2011, 11:1747-1760.
23. Nasti A., Zaki N.M., de Leonardis P., Ungphaiboon S., Sansongsak P., Rimoli M.G., et al. Chitosan/tpp and chitosan/tpp-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm Res 2009, 26:1918-1930.
24. Kasaai M.R., Arul J., Charlet C. Intrinsic viscosity-molecular weight relationship for chitosan. JPolym Sci Polym Phys 2000, 38:2591-2598.
25. Kaeuper P, Laue C, Kauper P. Hydrophilic particles, useful in a composition e.g. pharmaceutical composition and for transport and the concentration of biologically active substances in biological system, comprises chitosan and anionic polysaccharide. WO2007031812-A1; EP1968613-A1; US2008254078-A1.
26. Ungphaiboon S., Attia D., d'Ayala G.G., Sansongsak P., Cellesi F., Tirelli N. Materials for microencapsulation: what toroidal particles ("doughnuts") can do better than spherical beads. Soft Matter 2010, 6:4070-4083.
27. Kagan V.E., Tyurina Y.Y., Tyurin V.A., Konduru N.V., Potapovich A.I., Osipov A.N., et al. Direct and indirect effects of single walled carbon nanotubes on raw 264.7 macrophages: role of iron. Toxicol Lett 2006, 165:88-100.
28. Xia T., Kovochich M., Liong M., Madler L., Gilbert B., Shi H.B., et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134.
29. Huang M., Khor E., Lim L.Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 2004, 21:344-353.
30. Han Y.P., Zhao L.H., Yu Z.J., Feng J., Yu Q.Q. Role of mannose receptor in oligochitosan-mediated stimulation of macrophage function. Int Immunopharmacol 2005, 5:1533-1542.
31. Douglas K.L., Piccirillo C.A., Tabrizian M. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur J Pharm Biopharm 2008, 68:676-687.
32. Schwartz A.L., Fridovich S.E., Lodish H.F. Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma-cell line. JBiol Chem 1982, 257:4230-4237.
33. Krippendorff B.F., Kuester K., Kloft C., Huisinga W. Nonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosis. JPharmacokinet Pharmacodyn 2009, 36:239-260.
34. Ballatori N., Hager D.N., Nundy S., Miller D.S., Boyer J.L. Carrier-mediated uptake of lucifer yellow in skate and rat hepatocytes: a fluid-phase marker revisited. Am J Physiol Gastrointest Liver Physiol 1999, 277:G896-G904.
35. Zaki N.M., Tirelli N. Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting. Expert Opin Drug Deliv 2010, 7:895-913.
36. Behrens I., Pena A.I.V., Alonso M.J., Kissel T. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm Res 2002, 19:1185-1193.
37. Goncalves C., Mennesson E., Fuchs R., Gorvel J.P., Midoux P., Pichon C. Macropinocytosis of polyplexes and recycling of plasmid via the clathrin-dependent pathway impair the transfection efficiency of human hepatocarcinoma cells. Mol Ther 2004, 10:373-385.
38. van der Aa M., Huth U.S., Hafele S.Y., Schubert R., Oosting R.S., Mastrobattista E., et al. Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in cos-7 cells. Pharm Res 2007, 24:1590-1598.
39. Issa M.M., Koping-Hoggard M., Tommeraas K., Varum K.M., Christensen B.E., Strand S.P., et al. Targeted gene delivery with trisaccharide-substituted chitosan oligomers invitro and after lung administration invivo. JControl Release 2006, 115:103-112.
40. Gotte M., Feugaing D.D.S., Kresse H. Biglycan is internalized via a chlorpromazine-sensitive route. Cell Mol Biol Lett 2004, 9:475-481.
41. Qaddoumi M.G., Gukasyan H.J., Davda J., Labhasetwar V., Kim K.J., Lee V.H.L. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in plga nanoparticle endocytosis. Mol Vis 2003, 9:559-568.
42. Yang C.Y., Tai M.F., Lin C.P., Lu C.W., Wang J.L., Hsiao J.K., et al. Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology. PLoS One 2011, 6.
43. Tse S.M.L., Furuya W., Gold E., Schreiber A.D., Sandvig K., Inman R.D., et al. Differential role of actin, clathrin, and dynamin in fc gamma receptor-mediated endocytosis and phagocytosis. JBiol Chem 2003, 278:3331-3338.
44. Nakase I., Niwa M., Takeuchi T., Sonomura K., Kawabata N., Koike Y., et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 2004, 10:1011-1022.
45. Rejman J., Bragonzi A., Conese M. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol Ther 2005, 12:468-474.